LXEO - Lexeo Therapeutics, Inc.
7.2
-0.240 -3.333%
Share volume: 1,431,602
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$7.44
-0.24
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-13-2024 | 03-24-2025 | 05-12-2025 | 11-05-2025 | |
| Cash flow financing | 88.654 M | 291.000 K | -72.000 K | -97.000 K | 11.000 K | 52.000 K | |
| Other financing cash flows | -99.000 K | 345.000 K | -72.000 K | -93.000 K | -159.000 K | -49.000 K | |
| Cash flow | 73.594 M | -20.079 M | -17.961 M | -122.006 M | -6.105 M | 5.516 M | |
| Net income | -21.682 M | -21.238 M | -29.489 M | -25.924 M | -32.656 M | -20.283 M | |
| Depreciation | 69.000 K | 77.000 K | 83.000 K | 75.000 K | 60.000 K | 73.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -193.000 K | -218.000 K | -83.000 K | -93.583 M | 15.600 M | 35.011 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 185.000 K | 213.000 K | 83.000 K | 0.000 | 0.000 | 289.000 K | |
| Cash Change | 73.594 M | -20.079 M | -17.961 M | -122.006 M | -6.105 M | 5.516 M |